Hyperphosphorylation in ARSACS. – Dr. Anthony Hickey

In Recherche 2019 by ARSACS

To validate the misregulation of tau in ARSACS and establish a platform from which to explore therapeutic targeting of proteins involved in tau pathology as a treatment for ARSACS.

Grant: $98,758

Dr. Anthony Hickey, Director of UNC Catalyst for Rare Diseases, University of North Carolina                        120 Mason Farm Road CB# 7356 Chapel Hill NC 27599
Tel: (919) 962-9819

Interesting, right? Share with your friends & followers / Intéressant, non? Partagez avec vos amis: